GPB Scientific
https://gpbscientific.com/Reliable cell recovery and expansion are fundamental to the successful scale up of CAR-T or any therapeutic cell manufacturing process. GPB has developed a high-throughput, automatable, microfluidic closed-system for leukapheresis sample preparation and downstream processing of cells for CAR-T and other cell therapy production. This breakthrough reduces cell losses and skill-intensive manual steps.
Overview
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 8, 2020 | Daily funding roundup - April 7th, 2020 | Cyolo has raised $4.2M; Amphista Therapeutics secured $7.5M; Neat landed $11M Cyolo: Cyolo is a unified connectivity platform. Cyolo has raised $4.2 million in seed funding led by Flint Capital, with participation from Global Founders Capit... |
| Apr 6, 2020 | GPB Scientific Raises $25.5M in Financing | GPB Scientific, Inc., a Vista, Calif. and Richmond, Va.-based developer of breakthrough technologies for therapeutic cell production and bioprocessing, raised $25.5m in funding. The round was led by Vensana Capital alongside strategic inves... |
| Apr 2, 2020 | GPB Scientific Announces $25.5M Financing from Vensana Capital and Amgen Ventures | GPB Scientific, Inc., a developer of breakthrough technologies for therapeutic cell production and bioprocessing, today announced a $25.5 million funding commitment. The financing is led by Vensana Capital alongside strategic investor Amgen... |
| Apr 2, 2020 | GPB Scientific Secures $25.5M | VISTA, CA, GPB Scientific, a developer of breakthrough technologies for therapeutic cell production and bioprocessing, today announced a $25.5 million funding commitment. >> Click here for more funding data on GPB Scientific >&... |
| Jul 23, 2018 | Richmond's Top Venture Deals in 2018 (So Far) | In Virginia, 66 startups raised over $325 million in venture capital in the first six months of 2018, according to Pitchbook, a leading venture and M&A database that collects deal data in real-time. In Pitchbook's first half report... |
| GPB Scientific | “Advancing Cell Therapy Applications Beyond Today’s Limitations The Curate® Cell Processing System dramatically improves washing, separation and concentration of apheresis products for advanced cell therapies. Delivering a substantially gre... |
Reviews 0
FAQ about GPB Scientific
When was GPB Scientific founded?
GPB Scientific was founded in 2002.
How much funding has GPB Scientific raised?
GPB Scientific has raised $25.5M in total across 1 funding round.
What has the press written about GPB Scientific?
Parsers VC has collected 7 articles mentioning GPB Scientific, among them “Daily funding roundup - April 7th, 2020” (Apr 8, 2020) and “GPB Scientific Raises $25.5M in Financing” (Apr 6, 2020).
Is GPB Scientific still active?
Yes, GPB Scientific is active; its latest activity on Parsers VC dates from May 27, 2021.